Next Article in Journal
The Inflamed Intestinal Barrier as a Formulation Variable in Oral Nanocarrier Design: Evidence-Informed Principles for Mucus Interaction, Epithelial Access, and Translational Testing
Previous Article in Journal
Stability Study of a Frozen Oseltamivir 15 mg/mL Oral Solution in Amber Glass Bottles
Previous Article in Special Issue
Theranostic Potential of a New 64Cu-Labeled NOTA-R954 Peptide Conjugate for Kinin B1R Expressing Prostate Cancer
 
 
Article

Article Versions Notes

Pharmaceutics 2026, 18(9), 1131; https://doi.org/10.3390/pharmaceutics18091131
Action Date Notes Link
article html file updated 9 September 2026 05:50 CEST Original file https://www.mdpi.com/1999-4923/18/9/1131/html
article pdf uploaded. 9 September 2026 05:44 CEST Version of Record https://www.mdpi.com/1999-4923/18/9/1131/pdf
article xml uploaded. 9 September 2026 05:44 CEST Update https://www.mdpi.com/1999-4923/18/9/1131/xml
article xml file uploaded 9 September 2026 05:44 CEST Original file -
Back to TopTop